BridgeBio Pharma, Inc.
BBIO
$38.62
$0.280.73%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.63% | 155.74% | -40.52% | -13.84% | 19.50% |
| Total Receivables | 2,341.02% | 887.87% | -27.58% | -99.72% | 13,349.11% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.50% | 7.54% | 1.66% | 1.02% | 15.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -15.68% | -97.43% | 6.81% | 106,319.08% | -99.21% |
| Total Current Assets | -3.54% | 62.11% | -27.86% | -21.34% | 64.04% |
|
|
|||||
| Total Current Assets | -3.54% | 62.11% | -27.86% | -21.34% | 64.04% |
| Net Property, Plant & Equipment | 8.50% | -15.60% | -11.50% | -12.12% | -1.90% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 16.20% | -2.44% | -2.38% | -2.32% | -2.27% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.72% | -10.33% | 7.34% | -8.78% | -1.44% |
| Total Assets | -4.10% | 38.25% | -16.29% | -6.47% | 55.45% |
|
|
|||||
| Total Accounts Payable | 186.18% | -28.03% | -26.28% | 283.38% | -55.63% |
| Total Accrued Expenses | -16.78% | 18.51% | 16.15% | -17.67% | -6.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.60% | -2.04% | -0.50% | 1.74% | 10.08% |
| Total Finance Division Other Current Liabilities | -0.49% | -2.16% | -22.92% | -5.50% | 87.91% |
| Total Other Current Liabilities | -0.49% | -2.16% | -22.92% | -5.50% | 87.91% |
| Total Current Liabilities | -1.49% | 10.91% | 3.61% | -5.03% | -1.65% |
|
|
|||||
| Total Current Liabilities | -1.49% | 10.91% | 3.61% | -5.03% | -1.65% |
| Long-Term Debt | 7.36% | 0.12% | 0.10% | 0.10% | -0.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.66% | -19.49% | -17.37% | -14.92% | -7.62% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.76% | 2,512.46% | 8.93% | -14.84% | 118.83% |
| Total Liabilities | 6.03% | 26.21% | 0.37% | -0.52% | -0.14% |
|
|
|||||
| Common Stock & APIC | 1.85% | 1.44% | 1.35% | 1.65% | 22.95% |
| Retained Earnings | -5.41% | -9.36% | -6.07% | -2.83% | -1.38% |
| Treasury Stock & Other | -17.56% | 0.00% | 0.00% | 0.00% | -0.01% |
| Total Common Equity | -12.30% | -19.35% | -12.53% | -4.13% | 22.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.30% | -19.35% | -12.53% | -4.13% | 22.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -5.46% | -10.74% | 6.44% | -14.51% | 8.09% |
| Total Equity | -12.42% | -19.63% | -12.60% | -4.36% | 22.77% |
|
|
|||||